ACIPC 2026 International Conference: 8–11 November
The 2026 澳大利亚感染预防与控制学院 (ACIPC) International Conference will be held this November, both in person and online. Registrations are open now.
日期： 8–11 November 2026
地点： Gold Coast, Queensland and online
Learn more and register on the conference website.
Updated immunisation reference page: Pneumococcal
MVEC recently updated in pneumococcal reference page to reflect upcoming changes to the National Immunisation Program. From 1 July 2026, the vaccine Capvaxive will replace Prevenar 13 and Pneumovax 23 for adults.
The newly updated page includes information on Capvaxive administration and groups eligible to be vaccinated under the NIP.
TGA: Be alert to FluMist indicated age range
On 5 June the 治疗用品管理局 (TGA) released a safety update following reports of the live-attenuated influenza vaccine FluMist being administered to children to children under 2 years of age.
FluMist is not indicated for young children under 24 months of age. Health professionals are advised to confirm the child’s age before administration, and review FluMist product information.
Read the safety update in full at TGA: Be alert to FluMist indicated age range
For more information about influenza disease and vaccination, visit MVEC：流感
Aabi Award for the Influenza Champion(s) of the Year
Nominations are open until 31 July for the Immunisation Foundation of Australia’s Aabi Award, honouring Aabi’s memory.
The Aabi Award recognises people doing outstanding work to protect Australian families from influenza. Clinicians, researchers, community members, nurses, parents, pharmacists, teachers. Anyone whose work reflects Aabi’s spirit: protecting children, and the families who love them.
Read more on the Aabi Award website.
Benchmarque Group: RSV webinar in July
Next month, Benchmarque Group will host 2 sessions of a webinar focusing on the topic of RSV vaccination in older adults. Registrations are open now.
When: 1:00–2:00 pm AEST on 22 July 2026 OR 6:00–7:00 pm AEST on 23 July 2026
Learn more and register on the event page.
NIP: Adult pneumococcal vaccination – Program advice for health professionals
From 1 July 2026, Capvaxive will replace Prevenar 13 and Pneumovax 23 on the National Immunisation Program (NIP) for adults.
Capvaxive will be recommended and funded for:
- at-risk adults from 18 years with a specific medical condition
- First Nations adults from 25 years
- non-Indigenous adults without a risk condition from 65 years.
Read more at NIP: Adult pneumococcal vaccination – Program advice for health professionals.
Immunisation Coalition: Vale: Prof Allan Cripps memorial tribute webinar on pneumococcal disease
Next month, the Immunisation Coalition will host a webinar highlighting the new NIP schedule on pneumococcal disease.
日期： 2 July 2026
时间： 6:30–7:45 pm (AEST)
Learn more and register on the Immunisation Coalition’s event page.
BBC: Three Ebola vaccines in development amid growing outbreak fears
With more than 1,000 suspected cases of Ebola in DR Congo, three new vaccines are being developed to target the Bundibugyo species of Ebola linked to the current outbreak.
Read the article in full at BBC: Three Ebola vaccines in development amid growing outbreak fears.
Kids Health Info: The 2026 flu update with Dr Nigel Crawford (podcast)
MVEC Director Prof Nigel Crawford was recently a guest on the Royal Children’s Hospital’s Kids Health Info podcast.
Prof Crawford is the Director of SAEFVIC (Victorian safety reporting service) and MVEC, as well as medical head of the Royal Children’s Hospital Immunisation Service.
NCIRS: Pneumococcal vaccination for adults: expanding disease protection (webinar)
This month the 国家免疫研究和监测中心 (NCIRS) will hold a webinar addressing the 1 July changes to the adult pneumococcal vaccination program.
日期： 24 June 2026
时间： 12:00–1:30 pm AEST
Learn more and register on the webinar event page.